Sarah R. Klein
Cell Signaling Technology (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Immunotherapy and Immune Responses, Virus-based gene therapy research, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family(2016)556 cited
- → Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model(2015)426 cited
- → The myth of serum albumin as a measure of nutritional status(1990)159 cited
- → The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells(2009)154 cited
- → The Antioxidant Transcription Factor Nrf2 Negatively Regulates Autophagy and Growth Arrest Induced by the Anticancer Redox Agent Mitoquinone(2010)134 cited
- Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.(1984)
- Autophagy regulation in cancer development and therapy.(2011)
- → Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma(2017)72 cited
- → The E1B19K Oncoprotein Complexes with Beclin 1 to Regulate Autophagy in Adenovirus-Infected Cells(2011)54 cited
- → C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy(2015)48 cited